Cannabis Report
Home > Boards > US OTC > Medical - Healthcare >

VANC Pharmaceuticals Inc. (NUVPF)

Add NUVPF Price Alert      Hide Sticky   Hide Intro
Moderator: MERCURIAL, wingtrade, MrCheap
Search This Board: 
Last Post: 7/11/2018 3:08:12 PM - Followers: 12 - Board type: Free - Posts Today: 0

Vanc Pharmaceuticals Inc.



Canadian Exchange: TSXV Exchange  

News Links                                              




VANC Pharmaceuticals’ Vision for a New Future                             

VANCOUVER, British Columbia, May 03, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC”) (TSXV:VANC) (OTCQB:NUVPF) Board of Directors provided guidance on future company direction and initiatives today.

“In 2017 VANC had begun to anticipate secular changes affecting the generic and community pharmacy industries,” stated Mr. Bob Rai, CEO of VANC. “These changes included the trend towards increased funded participation by pharmacists in healthcare treatment of Canadians as well as dramatically shrinking margins on generic drugs. Our recent strategic partnerships, acquisitions and key personnel changes are a direct reflection of our vision, with a clear focus on growing beyond generics to provide pharmacists with innovative, value-added products, services and information to support their evolving business models and expanding role as front-line healthcare providers,” concluded Mr. Rai.

Concurrent with VANC’s new focus, the company will be reducing its generic portfolio over the next several months. Emerging opportunities in new healthcare sectors and the diminished ability to profit from generic sales drove this strategic decision. The realignment will provide existing products and services with increased focus and resources. This will also drive the expansion of a portfolio of high-margin over the counter (OTC) and point of care (POC) testing products and services that offer unique value to pharmacists, their patients, and consumers.

VANC is expanding its portfolio with announcements of strategic partnerships with Emerald, acquisition of the Corozon Platform, and plans to increase deployment of and expand offerings associated with HealthTab.

The recently announced strategic partnership with Emerald enables VANC to compete in the emerging medical cannabis sector with a line of endocannabinoid enhancers and with the potential to distribute medical cannabis to pharmacies when that avenue of sales is legalized.

“With a renewed focus on high-margin OTC/BTC product development, in addition to our recently announced partnership with Emerald Health, we anticipate generating increased sales and profitability in this pillar of the business in 2018,” explained Mr. Rai. “This shift in focus has also allowed us to engage with sales brokers across Canada, providing greater coverage to our products.”

The Corozon Platform, acquired in April 2018, offers a variety of functionalities including e-learning, e-commerce and potentially promotional modules. These capabilities ideally position it to serve as an anchor for this pillar of the business, functioning as an educational tool and distribution channel for a number of VANC products, including those the company will distribute for Emerald.

Mr. Rai added: “We will be able to leverage the Platform to promote our latest offerings and educate pharmacists on how to use them effectively. It will serve to drive our relationships with pharmacists and will also be a powerful retention tool. Through Corozon, we can efficiently market new services and products directly to the pharmacist.”

HealthTab will form the core of VANC’s future expansion of its point of care pharmacy screening tests to empower pharmacists and improve patient health. HealthTab as it is today will provide pharmacists with a platform to integrate precise blood chemistry into billable medicine reviews for patients in a timely and convenient manner.

“Our HealthTab service is based on a unique technology initially developed to provide a lab quality yet simple test for astronauts on the International Space Station. VANC can now provide this service to the general population. It will change how patients manage their health. It will also benefit the community by serving as a simple screening tool to detect serious conditions such as kidney failure or high cholesterol,” said Mr. Rai.

HealthTab systems have already been launched with strategic community pharmacy pilot programs in BC and Ontario. Furthermore, commitments for additional deployments have been secured and are scheduled for launch in Q2 2018. Additional tests to complement those currently offered by the HealthTab framework are in development and will make it best in class in terms of scope and accessibility to patients.

“The Emerald investment and licensing and the HealthTab and Corozon Platform acquisitions represent significant first steps in repositioning VANC. Further steps are being taken to create the structure and branding that will drive the evolution of our business to a new level in 2018,” concluded Mr. Rai.

About VANC Pharmaceuticals Inc. 

VANC Pharmaceuticals aims to become the partner of choice for forward-thinking pharmacies across Canada. With an established sales force, distribution network, and team of highly experienced professionals in pharmacy, point-of-care testing, and health technology, VANC is growing beyond generics to provide pharmacists with innovative, value-added products and services to expand their scope of practice and support their evolving role as front-line healthcare providers.

For more information, please contact Bob Rai at 604-247-2639 or by email at

Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves VANC’s expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. VANC generally uses words such as “outlook,” “will,” “could,” “would,” “might,” “remains,” “to be,” “plans,” “believes,” “may,” “expects,” “intends,” “anticipates,” “estimate,” “future,” “plan,” “positioned,” “potential,” “project,” “remain,” “scheduled,” “set to,” “subject to,” “upcoming,” and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to VANC as of the date of this release, and VANC assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of VANC and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Bob Rai, Director, and CEO

Primary Logo


Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NUVPF News: Amended Annual and Transition Report (foreign Private Issuer) (20-f/a) 06/19/2018 06:04:04 AM
NUVPF News: Annual and Transition Report (foreign Private Issuer) (20-f) 05/15/2018 05:32:05 PM
NUVPF News: Notification That Form 20-f Will Be Submitted Late (nt 20-f) 04/30/2018 02:36:28 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#187  Sticky Note Emerald Health Therapeutics Expands Strategic Investment in VANC wingtrade 05/12/18 03:48:21 PM
#130  Sticky Note Emerald Health Therapeutics to Launch Award-Winning Endocannabinoid Based MrCheap 04/30/18 02:55:12 PM
#118  Sticky Note VANC Announces Exclusive Sales Broker Agreement With Pinnacle MERCURIAL 04/30/18 12:30:19 PM
#256   $.12 nice work VANC wingtrade 07/11/18 03:08:12 PM
#255 talks about nuvpf !!! MADDSTACKER 06/28/18 03:57:44 PM
#254   Link? wingtrade 06/28/18 03:57:26 PM
#253   New interview out MADDSTACKER 06/28/18 03:56:08 PM
#252   Wow huge 583K share DUMP just now... wingtrade 06/28/18 03:54:58 PM
#251   Agreed MS, time will tell. Certainly there should wingtrade 06/28/18 02:25:49 PM
#250   Law just passed we got to give them MADDSTACKER 06/28/18 12:59:43 PM
#249   Another day, another tweet about the VANC HIV wingtrade 06/27/18 07:41:30 PM
#248   Agreed 100% ceo is sleeping at the wheel MADDSTACKER 06/22/18 10:42:53 AM
#247   That would be nice. Im so bitter about wingtrade 06/21/18 08:36:38 PM
#246   Would be nice to get a update now MADDSTACKER 06/21/18 11:28:31 AM
#245   Maybe they could start by proofreading their own wingtrade 06/20/18 04:10:57 PM
#244   Time to release some news. Senate passed, just MERCURIAL 06/19/18 07:32:53 PM
#243   NUVPF trading sub $.15 is pathetic! These guys wingtrade 06/19/18 01:25:59 PM
#242   Where's the news? Stop clowning around. $NUVPF MERCURIAL 06/19/18 12:55:36 PM
#241   Tweets don't make up for SP in the wingtrade 06/12/18 02:59:22 PM
#240   $VANC/ it. Drop the news that brings the MERCURIAL 06/06/18 11:56:33 AM
#239   I think we’re seeing the same things. Distribution MERCURIAL 06/05/18 08:45:08 PM
#238   Pinnacle Pharmaceutics and their partners will employ 23 wingtrade 06/05/18 07:30:01 PM
#237   VANC Bolsters Hema-Fer Market Presence with Amazon Canada wingtrade 06/05/18 07:28:50 PM
#236   The way I am reading the news about wingtrade 06/05/18 07:21:14 PM
#235   Exactly! wingtrade 06/05/18 02:47:07 PM
#234   This is gonna to sneak up on people. MERCURIAL 06/05/18 12:44:00 PM
#233   Thinking trying it for my wife ! MADDSTACKER 06/05/18 10:52:17 AM
#232   Nice. Good to know they arent abandoning that wingtrade 06/05/18 10:50:01 AM
#231   Looks like they're gonna try and corner the MERCURIAL 06/05/18 08:51:50 AM
#230   VANCOUVER, British Columbia, June 05, 2018 (GLOBE NEWSWIRE) MADDSTACKER 06/05/18 08:24:57 AM
#229 MADDSTACKER 06/05/18 08:24:28 AM
#228   Agreed! Excited to see if some major developments MERCURIAL 06/04/18 10:28:38 PM
#227   Loving that they have and are building high wingtrade 06/04/18 09:55:22 PM
#226   Let's go $VANC/NUVPF... MERCURIAL 06/04/18 09:33:07 AM
#225   NUVPF this low volune walkdown is pure BS!!! wingtrade 06/02/18 12:44:32 AM
#224   Til then im adding nomnom nom wingtrade 05/31/18 06:42:54 PM
#223   Law needs to pass , the they can MADDSTACKER 05/31/18 05:12:29 PM
#222   Low volume walk down BS, so annoying wingtrade 05/31/18 02:47:12 PM
#221   These prices are so frustrating, can't believe it! wingtrade 05/31/18 11:06:33 AM
#220   YW! Let’s get this train moving. Lol MERCURIAL 05/30/18 07:34:53 PM
#219   Thanks brother! MrCheap 05/30/18 07:31:28 PM
#218   Check out SEDAR. VANC Mgmt Discussion & Analysis MERCURIAL 05/30/18 07:21:45 PM
#217   Tick tock...ready for the chase to begin. $NUVPF $VANC MERCURIAL 05/30/18 10:11:25 AM
#216   When EMH exercises those warrants, it's game on. wingtrade 05/25/18 07:06:00 PM
#215   Drop some news on us VANC. About time MERCURIAL 05/23/18 10:08:12 AM
#214   I like cheap lol MrCheap 05/22/18 01:04:11 PM
#213   Not me. I like cheap shares. lol $NUVPF MERCURIAL 05/22/18 12:40:31 PM
#212   Everyone going wait till they announce license to MADDSTACKER 05/22/18 12:34:19 PM
#211   Yes it is, Bring them bulls!! $NUVPF MrCheap 05/21/18 10:31:16 AM
#210   Ready for the sector to get fired up. MERCURIAL 05/21/18 09:28:11 AM
#209   :) MrCheap 05/20/18 09:17:21 PM
#208 hot_n00b 05/20/18 12:26:40 AM
#207   For sure MADD! These products are actually pretty wingtrade 05/19/18 08:05:07 PM